Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Ms, Czuczman"'
Autor:
Andrew Zelenetz, Js, Abramson, Rh, Advani, Cb, Andreadis, Jc, Byrd, Ms, Czuczman, Fayad L, Forero A, Mj, Glenn, Jp, Gockerman, Li, Gordon, Nl, Harris, Rt, Hoppe, Sm, Horwitz, Ms, Kaminski, Yh, Kim, As, Lacasce, Ti, Mughal, Nademanee A, Porcu P, Press O, Prosnitz L, Reddy N, Smith MR, Sokol L, Swinnen L, Jm, Vose, Wg, Wierda, Yahalom J, Yunus F
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e8e00df83cbdacf02ae0bdc6935dd686
https://pubmed.ncbi.nlm.nih.gov/20202462
https://pubmed.ncbi.nlm.nih.gov/20202462
Autor:
Mahdi HS; Department of Obstetrics, Gynecology & Reproductive Sciences, Magee-Womens Hospital, University of Pittsburgh, Pittsburgh, PA, United States., Woodall-Jappe M; MWJ Scientific Consulting, Ipswich, MA, United States., Singh P; Clinical Development and Medical Affairs, Citius Pharmaceuticals, Inc., Cranford, NJ, United States., Czuczman MS; Clinical Development and Medical Affairs, Citius Pharmaceuticals, Inc., Cranford, NJ, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Oct 27; Vol. 14, pp. 1268979. Date of Electronic Publication: 2023 Oct 27 (Print Publication: 2023).
Autor:
McLaughlin P; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu., Grillo-López AJ; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu., Link BK; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu., Levy R; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu., Czuczman MS; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu., Williams ME; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu., Heyman MR; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu., Bence-Bruckler I; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu., White CA; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu., Cabanillas F; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu., Jain V; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu., Ho AD; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu., Lister J; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu., Wey K; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu., Shen D; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu., Dallaire BK; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jan 10; Vol. 41 (2), pp. 154-162.
Autor:
Sohani AR; Massachusetts General Hospital and Harvard Medical School, Boston, MA., Maurer MJ; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN., Giri S; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN., Pitcher B; The University of Texas MD Anderson Cancer Center, Houston, TX.; Alliance Statistics and Data Center, Duke University, Durham, NC., Chadburn A; Weill Cornell Medical College, New York, NY., Said JW; UCLA Medical Center, Los Angeles, CA., Bartlett NL; Washington University School of Medicine, St. Louis, MO., Czuczman MS; Celgene, Summit, NJ., Martin P; Weill Cornell Medical College, New York, NY., Rosenbaum CA; Weill Cornell Medical College, New York, NY., Jung SH; Alliance Statistics and Data Center, Duke University, Durham, NC., Leonard JP; Weill Cornell Medical College, New York, NY., Cheson BD; Medstar Georgetown University, Washington, DC., Hsi ED; Cleveland Clinic, Cleveland, OH.
Publikováno v:
The American journal of surgical pathology [Am J Surg Pathol] 2021 Mar 01; Vol. 45 (3), pp. 384-393.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2018 Nov 01; Vol. 29 (11), pp. 2271.
Autor:
Torka P; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY. Electronic address: pallawi.torka@roswellpark.org., Patel P; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY., Tan W; Department of Biostatistics, Roswell Park Cancer Institute, Buffalo, NY., Wilding G; Department of Biostatistics, Roswell Park Cancer Institute, Buffalo, NY., Bhat SA; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY., Czuczman MS; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY., Lee KP; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY; Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY., Deeb G; Department of Pathology, Roswell Park Cancer Institute, Buffalo, NY., Neppalli V; Department of Pathology, Roswell Park Cancer Institute, Buffalo, NY., Mavis C; Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY., Wallace P; Department of Flow Cytometry, Roswell Park Cancer Institute, Buffalo, NY., Hernandez-Ilizaliturri FJ; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY; Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2018 Jan; Vol. 18 (1), pp. e51-e60. Date of Electronic Publication: 2017 Nov 06.
Autor:
Gu JJ; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA., Singh A; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA., Xue K; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Mavis C; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA., Barth M; Department of Pediatric Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA., Yanamadala V; Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York, USA., Lenz P; Department of Physics, Philipps-University, Marburg, Germany., Grau M; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany., Lenz G; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany., Czuczman MS; Celgene, Summit, New Jersey, USA., Hernandez-Ilizaliturri FJ; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA.; Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York, USA.
Publikováno v:
Oncotarget [Oncotarget] 2017 Dec 19; Vol. 9 (3), pp. 4020-4033. Date of Electronic Publication: 2017 Dec 19 (Print Publication: 2018).
Autor:
Czuczman MS; Roswell Park Cancer Institute, Buffalo, New York. mczuczman@celgene.com., Trněný M; Department of Hematology, Charles University Hospital, Prague, Czech Republic., Davies A; Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Rule S; Department of Haematology, Derriford Hospital, Plymouth, United Kingdom., Linton KM; Division of Molecular and Clinical Cancer Sciences, The Christie Foundation Trust, Manchester, United Kingdom., Wagner-Johnston N; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri., Gascoyne RD; Centre for Lymphoid Cancers, BC Cancer Agency, Vancouver, British Columbia, Canada., Slack GW; Centre for Lymphoid Cancers, BC Cancer Agency, Vancouver, British Columbia, Canada., Brousset P; Laboratoire D'Anatomie Pathologique, Centre Hospitalier Universitaire Purpan, Toulouse, France., Eberhard DA; Department of Pathology/Laboratory Medicine and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Hernandez-Ilizaliturri FJ; Roswell Park Cancer Institute, Buffalo, New York., Salles G; Hematology Department, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Benite, France., Witzig TE; Departments of Laboratory Medicine and Pathology and Hematology, Mayo Clinic, Rochester, Minnesota., Zinzani PL; Institute of Hematology and Medical Oncology, University of Bologna, Bologna, Italy., Wright GW; Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Staudt LM; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Yang Y; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Williams PM; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland., Lih CJ; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc. and Frederick National Laboratory for Cancer Research, Frederick, Maryland., Russo J; Celgene Corporation, Summit, New Jersey., Thakurta A; Celgene Corporation, Summit, New Jersey., Hagner P; Celgene Corporation, Summit, New Jersey., Fustier P; Celgene Corporation, Boudry, Switzerland., Song D; Celgene Corporation, Summit, New Jersey., Lewis ID; Divison of Haematology, Royal Adelaide Hospital and University of Adelaide, Adelaide, Australia.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Aug 01; Vol. 23 (15), pp. 4127-4137. Date of Electronic Publication: 2017 Apr 05.
Autor:
Gu JJ; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.; Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY, USA., Kaufman GP; Department of Internal Medicine, Mayo Clinic, Rochester, MN, Celgene Corporation, Summit, NJ, USA., Mavis C; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.; Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY, USA., Czuczman MS, Hernandez-Ilizaliturri FJ; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.; Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY, USA.
Publikováno v:
Oncotarget [Oncotarget] 2017 Feb 21; Vol. 8 (8), pp. 12741-12753.
Autor:
Lamonica D; Departments of Medicine and Nuclear Medicine, Roswell Park Cancer Institute, Buffalo, New York dominick.lamonica@roswellpark.org., Graf DA; Nuclear Medicine Residency, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York., Munteanu MC; Clinical Development, Teva Branded Pharmaceutical Products Research & Development, Inc., Frazer, Pennsylvania; and., Czuczman MS; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2017 Jan; Vol. 58 (1), pp. 62-68. Date of Electronic Publication: 2016 Jul 28.